LFVN - Lifevantage Corp
4.91
0.110 2.240%
Share volume: 161,835
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$4.80
0.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 05-02-2024 | 10-29-2024 | 10-29-2024 | 02-05-2025 | 05-06-2025 | 09-04-2025 | 11-04-2025 | 02-04-2026 | |
| Assets | |||||||||
| Total Assets | 61.307 M | 60.299 M | 61.460 M | 68.527 M | 77.237 M | 71.958 M | 61.579 M | 61.169 M | |
| Current Assets | 37.797 M | 37.646 M | 38.815 M | 45.790 M | 54.114 M | 50.894 M | 45.048 M | 38.557 M | |
| Inventories | 15.162 M | 15.055 M | 16.914 M | 17.467 M | 22.221 M | 20.669 M | 20.594 M | 18.978 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 17.377 M | 16.886 M | 14.596 M | 21.595 M | 22.469 M | 20.201 M | 13.091 M | 10.181 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 8.349 M | 7.813 M | 7.477 M | 7.136 M | 6.730 M | 6.207 M | 5.997 M | 6.426 M | |
| Other Assets | 15.161 M | 14.840 M | 15.168 M | 15.601 M | 16.393 M | 14.857 M | 10.534 M | 16.186 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 61.307 M | 60.299 M | 61.460 M | 68.527 M | 77.237 M | 71.958 M | 61.579 M | 61.169 M | |
| Total liabilities | 34.538 M | 34.308 M | 33.763 M | 38.638 M | 43.226 M | 37.317 M | 28.422 M | 28.182 M | |
| Total current liabilities | 22.475 M | 22.309 M | 22.072 M | 27.549 M | 32.583 M | 27.217 M | 18.829 M | 19.013 M | |
| Accounts Payable | 6.954 M | 5.853 M | 5.270 M | 5.757 M | 7.038 M | 4.600 M | 4.356 M | 4.891 M | |
| Other liabilities | 211.000 K | 198.000 K | 225.000 K | 206.000 K | 218.000 K | 289.000 K | 283.000 K | 369.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 211.000 K | 198.000 K | 225.000 K | 206.000 K | 218.000 K | 289.000 K | 283.000 K | 369.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 26.769 M | 25.991 M | 27.697 M | 29.889 M | 34.011 M | 34.641 M | 33.157 M | 32.987 M | |
| Common stock | 136.199 M | 136.645 M | 137.348 M | 138.172 M | 139.069 M | 139.963 M | 137.653 M | 138.042 M | |
| Retained earnings | -107.709 M | -108.738 M | -108.526 M | -106.478 M | -103.511 M | -104.147 M | -103.141 M | -103.441 M |